Aim: There are a number of vaccines against SARS CoV-2 used to create immunity belt to reduce the infections, therefore we decided to conduct a questionare study among the vaccinated persons from different countries to find the vaccine effectiveness. Method: A telephone as well as person meeting were conducted with 30 different vaccinated with the following questions: how many times they vaccinated were, how many times have they gotten the breakthrough infections and how long was this infection. Results: The analysis indicate that almost all vaccinated persons have breakthrough infection. The airtravel was discovered as one of causes, where some got the breakthrough infections. There were a few fatalities, but the hospitalization was rare...
International audienceObjectives: The diffusion of the SARS-CoV-2 Delta (B.1.617.2) variant and the ...
International audienceObjectives: The diffusion of the SARS-CoV-2 Delta (B.1.617.2) variant and the ...
International audienceObjectives: The diffusion of the SARS-CoV-2 Delta (B.1.617.2) variant and the ...
Introduction: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is spreading rapidly arou...
More than 7 billion vaccinations against SARS-CoV-2 have now been administered.1 Clinical trials and...
BACKGROUND: While the vaccines against COVID-19 are highly effective, COVID-19 vaccine breakthrough ...
Since the first case of coronavirus disease 2019 (COVID-19) was reported in December 2019, there hav...
The global effort to vaccinate people against SARS-CoV-2 in the midst of an ongoing pandemic has rai...
(1) Background: Some COVID-19 vaccine recipients show breakthrough infection. It remains unknown, wh...
Vaccine breakthrough COVID-19 infections are increasingly occurring in fully vaccinated individuals,...
(1) Background: Some COVID-19 vaccine recipients show breakthrough infection. It remains unknown, wh...
: In recent weeks, the rate of SARS-CoV-2 infections has been progressively increasing all over the ...
: In recent weeks, the rate of SARS-CoV-2 infections has been progressively increasing all over the ...
Background Data on breakthrough SARS-CoV-2 Delta variant infections in vaccinated individuals are li...
Vaccine breakthrough COVID-19 infections are increasingly occurring in fully vaccinated individuals,...
International audienceObjectives: The diffusion of the SARS-CoV-2 Delta (B.1.617.2) variant and the ...
International audienceObjectives: The diffusion of the SARS-CoV-2 Delta (B.1.617.2) variant and the ...
International audienceObjectives: The diffusion of the SARS-CoV-2 Delta (B.1.617.2) variant and the ...
Introduction: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is spreading rapidly arou...
More than 7 billion vaccinations against SARS-CoV-2 have now been administered.1 Clinical trials and...
BACKGROUND: While the vaccines against COVID-19 are highly effective, COVID-19 vaccine breakthrough ...
Since the first case of coronavirus disease 2019 (COVID-19) was reported in December 2019, there hav...
The global effort to vaccinate people against SARS-CoV-2 in the midst of an ongoing pandemic has rai...
(1) Background: Some COVID-19 vaccine recipients show breakthrough infection. It remains unknown, wh...
Vaccine breakthrough COVID-19 infections are increasingly occurring in fully vaccinated individuals,...
(1) Background: Some COVID-19 vaccine recipients show breakthrough infection. It remains unknown, wh...
: In recent weeks, the rate of SARS-CoV-2 infections has been progressively increasing all over the ...
: In recent weeks, the rate of SARS-CoV-2 infections has been progressively increasing all over the ...
Background Data on breakthrough SARS-CoV-2 Delta variant infections in vaccinated individuals are li...
Vaccine breakthrough COVID-19 infections are increasingly occurring in fully vaccinated individuals,...
International audienceObjectives: The diffusion of the SARS-CoV-2 Delta (B.1.617.2) variant and the ...
International audienceObjectives: The diffusion of the SARS-CoV-2 Delta (B.1.617.2) variant and the ...
International audienceObjectives: The diffusion of the SARS-CoV-2 Delta (B.1.617.2) variant and the ...